Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults

American Journal of Kidney Diseases

Volumn 62, Issue 1, 2013, Pages 42-51

  Foster, Meredith C ^a,b   Inker, Lesley A ^c   Levey, Andrew S ^c   Selvin, Elizabeth ^a,b,d   Eckfeldt, John ^e   Juraschek, Stephen P ^a,b,d   Coresh, Josef ^a,b,d,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cystatin C; estimated glomerular filtration rate; mortality; Third National Health and Nutrition Examination Survey; trace protein

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; PROSTAGLANDIN D SYNTHASE; UNCLASSIFIED DRUG;

ADULT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REVIEW; UNITED STATES;

EID: 84879411450     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.01.016     Document Type: Article

References (54)

1. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
2. K. Matsushita, B.K. Mahmoodi, M. Woodward Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration rate JAMA 307 18 2012 1941 1951
3. A.S. Levey, J. Coresh Chronic kidney disease Lancet 379 9811 2012 165 180
4. M.G. Shlipak, M.J. Sarnak, R. Katz Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 20 2005 2049 2060
5. L.A. Stevens, J. Coresh, T. Greene, A.S. Levey Assessing kidney function - measured and estimated glomerular filtration rate N Engl J Med 354 23 2006 2473 2483
6. A.D. Rule, K.R. Bailey, G.L. Schwartz, S. Khosla, J.C. Lieske, L.J. Melton III For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics Kidney Int 75 10 2009 1071 1078
7. A.S. Levey, K.U. Eckardt, Y. Tsukamoto Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 67 6 2005 2089 2100
8. L.A. Inker, C.H. Schmid, H. Tighiouart Estimating glomerular filtration rate from serum creatinine and cystatin C N Engl J Med 367 1 2012 20 29
9. L.A. Stevens, C.H. Schmid, T. Greene Factors other than glomerular filtration rate affect serum cystatin C levels Kidney Int 75 6 2009 652 660
10. M.G. Shlipak, M.L. Praught, M.J. Sarnak Update on cystatin C: new insights into the importance of mild kidney dysfunction Curr Opin Nephrol Hypertens 15 3 2006 270 275
11. A. Hoffmann, M. Nimtz, H.S. Conradt Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases Glycobiology 7 4 1997 499 506
12. G.H. Schardijn, L.W. Statius van Eps Beta 2-microglobulin: its significance in the evaluation of renal function Kidney Int 32 5 1987 635 641
13. F. Priem, H. Althaus, M. Birnbaum, P. Sinha, H.S. Conradt, K. Jung Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range Clin Chem 45 4 1999 567 568
14. 2-microglobulin as marker of GFR Ren Fail 23 3-4 2001 419 429
15. 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine J Pharm Biomed Anal 24 5-6 2001 835 842
16. R.P. Woitas, B. Stoffel-Wagner, U. Poege, P. Schiedermaier, U. Spengler, T. Sauerbruch Low-molecular weight proteins as markers for glomerular filtration rate Clin Chem 47 12 2001 2179 2180
17. U. Poge, T.M. Gerhardt, B. Stoffel-Wagner Beta-trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients Clin Chem 51 8 2005 1531 1533
18. C.A. White, A. Akbari, S. Doucette Estimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations Kidney Int 76 7 2009 784 791
19. C.A. White, A. Akbari, S. Doucette A novel equation to estimate glomerular filtration rate using beta-trace protein Clin Chem 53 11 2007 1965 1968
20. C. Donadio Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary beta-trace protein Am J Physiol Renal Physiol 299 6 2010 F1407 F1423
21. N.A. Bhavsar, L.J. Appel, J.W. Kusek Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD Am J Kidney Dis 58 6 2011 886 893
22. N. Tangri, L.A. Inker, H. Tighiouart Filtration markers may have prognostic value independent of glomerular filtration rate J Am Soc Nephrol 23 2 2012 351 359
23. M. Hoke, E. Pernicka, A. Niessner Renal function and long-term mortality in patients with asymptomatic carotid atherosclerosis Thromb Haemost 107 1 2011
24. B.C. Astor, T. Shafi, R.C. Hoogeveen Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population Am J Kidney Dis 59 5 2012 653 662
25. 2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein Arch Intern Med 168 2 2008 200 206
26. K.S. Spanaus, B. Kollerits, E. Ritz Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease Clin Chem 56 5 2010 740 749
27. T. Shafi, R.S. Parekh, B.G. Jaar Serum beta-trace protein and risk of mortality in incident hemodialysis patients Clin J Am Soc Nephrol 7 9 2012 1435 1445
28. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. National Center for Health Statistics Vital Health Stat. 1 32 1994
29. A. Kottgen, E. Selvin, L.A. Stevens, A.S. Levey, F. Van Lente, J. Coresh Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 51 3 2008 385 394
30. Centers for Disease Control and Prevention, National Center for Health Statistics Data access-data linkage activities-NHANES III mortality linkage http://www.cdc.gov/nchs/data-access/data-linkage/mortality/nhanes3-linkage.htm Accessed January 6, 2013
31. National Center for Health Statistics, Office of Analysis and Epidemiology The Third National Health and Nutrition Examination Survey (NHANES III) linked mortality file, mortality follow-up through 2006: matching methodology May 2009, Hyattsville, MD http://www.cdc.gov/nchs/data/datalinkage/ matching-methodology-nhanes3-final.pdf Accessed January 6, 2013
32. E. Selvin, J. Manzi, L.A. Stevens Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004 Am J Kidney Dis 50 6 2007 918 926
33. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) Third National Health and Nutrition Examination Survey 1988-1994 documentation, codebook, and frequencies, surplus sera laboratory component: cystatin C (surplus sera) ftp://ftp.cdc.gov/pub/Health-Statistics/ NCHS/nhanes/nhanes3/27a/SSCYSTAT.pdf Accessed January 6, 2013
34. 2 microglobulin (SSNH3BTP) http://www.cdc.gov/nchs/nhanes/ nhanes3/SSNH3BTP.htm Accessed January 6, 2013
35. E. Selvin, S.P. Juraschek, J. Eckfeldt, A.S. Levey, L.A. Inker, J. Coresh Within-person variability in kidney measures [published online ahead of print January 18, 2013] Am J Kidney Dis. http://dx.doi.org/10.1053/j.ajkd.2012.11.048
36. 2-microglobulin assays after long-term sample storage Clin Biochem 45 9 2012 694 696
37. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
38. R.N. Anderson, A.M. Minino, D.L. Hoyert, H.M. Rosenberg Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates Natl Vital Stat Rep 49 2 2001 1 32
39. A. Zellner An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias J Am Stat Assoc 57 298 1962 348 368
40. M.J. Pencina, R.B. D'Agostino Sr, E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 1 2011 11 21
41. T. Shafi, K. Matsushita, E. Selvin Comparing the association of GFR estimated by the CKD-EPI and MDRD Study equations and mortality: the Third National Health and Nutrition Examination Survey (NHANES III) BMC Nephrol 13 2012 42
42. N. Neirynck, S. Eloot, G. Glorieux Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease PLoS One 7 8 2012 e44201
43. S. Eloot, E. Schepers, D.V. Barreto Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins Clin J Am Soc Nephrol 6 6 2011 1266 1273
44. E.L. Knight, J.C. Verhave, D. Spiegelman Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement Kidney Int 65 4 2004 1416 1421
45. 2-microglobulin, cystatin C, and creatinine in the US population [published online ahead of print January 18, 2013]. Clin J Am Soc Nephrol. doi:10.2215/CJN.08700812.
46. Y. Eguchi, N. Eguchi, H. Oda Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients Proc Natl Acad Sci U S A 94 26 1997 14689 14694
47. T. Inoue, Y. Eguchi, T. Matsumoto Lipocalin-type prostaglandin D synthase is a powerful biomarker for severity of stable coronary artery disease Atherosclerosis 201 2 2008 385 391
48. H.H. Chen Beta-trace protein versus cystatin C: which is a better surrogate marker of renal function versus prognostic indicator in cardiovascular diseases? J Am Coll Cardiol 57 7 2011 859 860
49. 2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies Circulation 116 12 2007 1396 1403
50. 2- microglobulin to arterial stiffness in Japanese subjects Hypertens Res 28 6 2005 505 511
51. B.O. Eriksen, U.D. Mathisen, T. Melsom The role of cystatin C in improving GFR estimation in the general population Am J Kidney Dis 59 1 2012 32 40
52. R. Bataille, M. Magub, J. Grenier, D. Donnadio, J. Sany Serum beta-2-microglobulin in multiple myeloma: relation to presenting features and clinical status Eur J Cancer Clin Oncol 18 1 1982 59 66
53. D. Rossi, M. Fangazio, L. De Paoli Beta-2-microglobulin is an independent predictor of progression in asymptomatic multiple myeloma Cancer 116 9 2010 2188 2200
54. C.A. Peralta, M.G. Shlipak, S. Judd Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality JAMA 305 15 2011 1545 1552